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Survivin Is Required for Beta-Cell Mass Expansion in the
Pancreatic Duct-Ligated Mouse Model
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Abstract
Aims/Hypothesis: Pancreatic beta-cell mass expands through adulthood under certain conditions. The related molecular
mechanisms are elusive. This study was designed to determine whether surviving (also known as Birc5), which is transiently
expressed perinatally in islets, was required for beta-cell mass expansion in the pancreatic duct-ligated mouse model.
Methods: Mice with beta cell–specific deletion of survivin (RIPCre+survivinfl/fl) and their control littermates (RIPCre+survivin+/
+
) were examined to determine the essential role of survivin in partial pancreatic duct ligation (PDL)-induced beta-cell
proliferation, function and survival.
Results: Resurgence of survivin expression occurred as early as day 3 post-PDL. By day 7 post-PDL, control mice showed
significant expansion of beta-cell mass and increase in beta-cell proliferation and islet number in the ligated tail of the
pancreas. However, mice deficient in beta-cell survivin showed a defect in beta-cell mass expansion and proliferation with
a marked attenuation in the increase of total islet number, largely due to an impairment in the increase in number of larger
islets while sparing the increase in number of small islets in the ligated tail of pancreas, resulting in insufficient insulin
secretion and glucose intolerance. Importantly however, beta cell neogenesis and apoptosis were not affected by the
absence of survivin in beta cells after PDL.
Conclusions/Interpretation: Our results indicate that survivin is essential for beta-cell mass expansion after PDL. Survivin
appears to exhibit a preferential requirement for proliferation of preexisting beta cells.
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response to pancreatic injury, in a manner reminiscent of
embryonic endocrine cell differentiation.
Survivin (also known as Birc5) is the smallest member of the
inhibitor of apoptosis protein (IAP) gene family [6]. Initially,
survivin was described as an anti-apoptosis gene [7]. However,
further studies have revealed that survivin is a multifunctional
protein that intersects fundamental networks of cellular processes,
including cell death, cell division and cellular adaptation [8–10].
Germline deletion of survivin leads to early embryonic lethality at
E3.5 [11]. Tissue-specific knockout of survivin in thymocytes,
neuronal precursors, endothelial cells or haematopoietic progenitors resulted in impaired cell proliferation, cell cycle arrest,
apoptosis, or mitotic spindle formation, illustrating a complex
physiological role for survivin in normal cell development [12–15].
Previous studies have shown that survivin is expressed in beta
cells of fetal human pancreas,but not in adult islets [16,17].

Introduction
As type 1 and type 2 diabetes result from absolute or relative
deficiencies in beta-cell mass, respectively, understanding how
beta-cell mass is regulated can lead to new therapeutic options.
Beta cells replicate slowly after birth [1], but proliferation can be
stimulated under various conditions, including obesity, pregnancy
and in response to growth factors [2]. However, the mechanism by
which new beta cells are formed in adults is still controversial.
Genetic lineage tracing studies provide evidence that pre-existing
beta cells, rather than stem/progenitor cells, are the major source
of new beta cells in adult mice both under normal physiological
conditions and after 50% to 70% pancreatectomy [3,4]. However,
a recent study [5] in mice has shown that new beta cells are
generated from facultative adult progenitor cells (neogenesis) in
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stimulated insulin secretion (GSIS) measurements were performed at day 7 post-surgery as previously described [23]. Serum
insulin levels were measured by ELISA with rat/mouse insulin
standards (Linco, USA).

However, survivin is also found in the beta cells in areas of chronic
pancreatitis and within lobular areas of surviving islets of
pancreata of patients with presumed type 1A (immune-mediated)
childhood-onset diabetes [18,19]. We previously showed that
transient perinatal expression of survivin is essential for pancreatic
beta-cell mass establishment by regulation of cell cycle progression
[20]. Specific deletion of survivin in beta cells does not affect
embryonic pancreas or beta-cell development but does impair
beta-cell mass expansion, resulting in progressive diabetes in adult
male mice [20,21]. However, female mice remain glucose tolerant
despite relatively reduced beta-cell mass and thus are the focus of
this study, allowing for analysis of adult beta-cell expansion
without the confounding effects of pre-existing hyperglycemia.
To determine whether survivin is required for beta-cell
expansion in adults, we performed partial pancreatic duct ligation
(PDL) on adult female RIPCre+survivinfl/fl mice and control
(RIPCre+survivin+/+) littermates. Here, we show that survivin,
which was absent in adult pancreas was induced within beta cells
in the ligated tail of pancreas following PDL during the period of
peak regeneration, and that expansion of beta-cell mass following
PDL was impaired in RIP-Cre+survivinfl/fl mice due to reduced
beta-cell proliferation.

Islet Isolation
Pancreatic islets were isolated from 2-week-old mice and ligated
tail portion of the mice at day 7 post-surgeryby injecting
collagenase V (2 mg/ml; Sigma-Aldrich, USA) into the pancreas.
Pancreata was then allowed to digest in the collagenase solution at
37uC with shaking for 15–20 min. Digestion was stopped by icecold Hanks’ balanced salt solution (HBSS) containing 10% (vol./
vol.) FCS. Islets were then hand-picked under a dissecting
microscope.

Western Blotting
Islet-, liver- and kidney-protein lysates were obtained as
previously described [24]. Lysates were separated by SDS-PAGE
and immunoblotted with antibodies against survivin (Novus
Biologicals, USA), p21 and caspase-3 (BD Pharmingen, USA),
Aurora Bkinase (Abcam, USA), v-akt murine thymoma viral
oncogenes (AKT), phosphorylatedAKT (Ser473), cleaved caspase3 (Asp175) and glyceraldehyde phosphate dehydrogenase
(GAPDH) (Cell Signaling Technology, USA). Densitometric
quantification of protein bands was analyzed using Image J
software version 1.37. Samples were normalized to GADPH.

Methods
Mice
Survivinfl/fl mice [12], were mated with mice carrying the Cre
transgene under the control of the rat insulin 2 promoter
[TgN(ins2-cre)25 Mgn, hereafter referred to as RIPcre; Jackson
Laboratories]. RIPcre+survivin+/fl mice were intercrossed to
generate RIPcre+survivin+/+, RIPcre+survivin+/fl and RIPcre+survivinfl/fl mice. Only wild-type (RIPcre+survivin+/+) littermates
were used as controls. Genotypes for the cre and survivin genes were
determined by PCR using mouse tail DNA. PCR primers for
survivin (GeneID:11799) were as follows: forward 59TGAGTCGTCTTGGCGGAGGTTGT-39,
reverse
59GCTCGTTCTCGGTAGGGCAGTGG-39. All mice were maintained on C57BL/6 background, housed in a pathogen-free
facility on a 12-hr light-dark cycle, and fed ad libitum with
standard irradiated rodent chow in accordance with Ontario
Cancer Institute Animal Care Facility Protocol, without restriction
on animal activity. Animal care and experimental protocols were
approved by the Nanjing Medical University Animal Care
Committee.

Immunohistochemistry, Immunofluorescence Staining,
and Islet Morphometry
Pancreata were fixed in 4% paraformaldehyde. Samples were
dehydrated and prepared as paraffin blocks. Serial seven mm-thick
pancreatic sections were obtained with at least 3 levels per slide
separated by 100–150 mm intervals and stained with hematoxylin
and eosin, insulin (DAKO) and survivin. Beta-cell proliferation
was assessed by Ki67 (Novus Biologicals, USA) and apoptosis was
detected using In Situ Cell Death Detection Kit (Roche, USA).
Double immunofluorescence staining was performed for insulin
with survivin or glucagon (NovoCastra Laboratories) and slides
were examined using a Zeiss inverted fluorescent microscope.
Total beta-cell mass at two month of age and day 7 after PDL
were determined on insulin-immunostained sections and calculated by multiplying the pancreatic weight by the ratio of beta-cell
area to total pancreatic area. Islet number and beta-cell number
and size were calculated on insulin-immunostained sections.
According to the nucleus numbers, islets were divided into small
islets (1–10 nuclei) and larger islets (.10 nuclei).

Surgical Procedure and Tissue Preparation
Two-month-old female mice were anesthetized using isoflurane,
and laparotomy was performed through a midline abdominal
incision. Pancreatic ducts of the gastric and splenic segments were
ligated as described [22]. Partial PDL was carefully made from the
point where the pancreas is attached to the first portion of the
duodenum to the point just before its attachment to the transverse
colon. The ligated tail portion accounts for 50–60% of the entire
pancreas. For sham operations, the pancreas was gently touched
with a moistened cotton-tipped swab for 1 min. Pancreatic head
and tail portions were harvested at 3, 7 and 14 days of postsurgery. These specimens were processed separately for weight
determination, prior to fixation and embedding in paraffin.

Quantitative Real-time PCR
Total RNA was isolated from ligated pancreas tail at day 7 postsurgery with TRIzol reagent (Invitrogen Life Technologies
Inc.,Carlsbad, CA, USA). The cDNA was synthesized from 1 mg
RNA using M-MLV reverse transcription system (Promega,
Madison, WI, USA). Primers used are listed in Table S1. Realtime RT-PCR analyses were performed using SYBR Green
Supermix kit in ABI Prism 7900 HT real-time PCR system
(Applied Biosystems, Foster City, CA, USA). The relative levels of
gene expression were normalized by the internal control GAPDH.
Each sample was run in triplicate, and each experiment included
three nontemplate control wells.

Metabolic Studies and Hormone Measurements
All overnight-fasts were carried out between 6 pm to 8 am.
Blood glucose levels were determined with mouse tail venous
blood using an automated glucometer (Roche, Germany).
Intraperitoneal glucose tolerance tests (IPGTT) and glucosePLoS ONE | www.plosone.org

Statistical Analysis
Data are presented as means 6 SE and were analyzed by
unpaired student’s t-test and one-way analysis of variance with the
2
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survivin was not detectable in the whole pancreas in the tail of day
7 sham-operated pancreas, but regained its expression throughout
the pancreatic epithelium including islet beta cells in the tail of
pancreas7 days after PDL (Fig. 1c).

post-hoc Tukey test. Differences were considered to be statistically
significant when P,0.05.

Results
PDL Induces Survivin Expression and Promotes Beta-cell
Mass Expansion

Generation of Beta-cell-specific Survivin-deficient Mice
To investigate the essential role of survivin induction in the
expansion of pancreatic beta-cell mass, we generated a rat insulin
promoter (RIP)-driven survivin knockout mouse by Cre-loxP
recombination system. The resultant RIPcre+survivinfl/fl mice had
deletion of survivin specifically in pancreatic beta cells and efficient
deletion in the islets in both sexes (Fig. 2a–d). PCR analyses
confirmed the presence of the deleted allele specifically in islets of
RIPcre+survivinfl/flmice (Fig. 2c). The expression of survivin in
other tissues, including the liver and kidney, was unaffected
(Fig. 2d).
RIPcre+survivinfl/fl mice were born at expected Mendelian
frequencies and survived past weaning. Because of the lack of
survivin expression during embryonic development and neonatal
period, the mutant mice exhibited a decreased beta-cell mass at 2month of age as compared to controls. The male mutant mice had

In C57BL/6 mice, the duct leading to the pancreatic tail was
closed while the organ’s head located adjacent to the stomach and
duodenum remained unaffected. Within two weeks, the beta-cell
mass in the ligated part of pancreas increased more than 2-fold
following surgery, and beta-cell proliferation increased 9-fold
determined by ki67 staining (Fig. 1a). No difference in beta-cell
mass and proliferation was found in the non-ligated portion (head)
of the pancreas (Fig. 1a).
Previous reports showed survivin to be present in mouse
pancreatic islets transiently during embryonic development and
neonatal period, and become undetectable by 2-month of age
[20,21]. We found that survivin was induced in the islets of the
ligated tail of pancreas within 2 weeks after PDL,reaching its peak
at PDL day 7 (Fig. 1b). Immunofluorescent staining showed that

Figure 1. PDL activates survivin expression and promotes beta-cell mass expansion. (a) PDL markedly increased beta-cell mass (left panel)
and beta-cell proliferation (right panel) in the tail part of pancreas (black bars) at day 3, 7 and 14 as compared to the unligated head of the same
pancreas (gray bars) and the tail of a sham-operated pancreas (white bars) (n = 5 at each time point). **P,0.01. (b) Western blots (left panel) and
quantification (right panel) show that survivin expression is detected in the ligated tail of 8-week-old mouse pancreas from PDL day3 to 14 (n = 5 at
each time point). Compared to D3, **p,0.01. (c) Immunofluorescent staining shows that survivin is not expressed in the whole pancreas in the tail of
day 7 sham-operated pancreas, but reexpressed throughout the pancreatic epithelium including islet beta cells in the tail of pancreas at PDL day 7
(original magnification, 6200). The data represent as means 6 SE.
doi:10.1371/journal.pone.0041976.g001
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Figure 2. Beta cell-specific deletion of survivin. (a) Immunohistochemistry showing survivin deletion in pancreatic beta cells at P1 from
RIPcre+survivinfl/fl mice (original magnification, 6400). (b) Western blots (left panel) and quantification (right panel) showing decreased expression of
survivin in isolated islets from RIPcre+survivinfl/fl mice in both sexes (n = 5 per genotype). Mutant mice, white bars; controls, black bars. (c) PCR
analysis of Cre-mediated recombination of the survivin locus (Dflox) in islet and mouse tail DNA. (d) Expression of survivin in the liver and kidney is
unchanged. +/+, RIPcre+survivin+/+ mice; 2/2, RIPcre+survivinfl/fl mice; wt, wildtype. The data represent as means 6 SE. **, p,0.01vs control.
doi:10.1371/journal.pone.0041976.g002

effects of pre-existing glucose intolerance on beta-cell expansion.
The mutant mice exhibited markedly higher glucose excursion
compared to controls (Fig. 4a). To further understand this process,
we assessed for beta-cell function by GSIS. Insulin secretion in
response to an i.p. glucose challenge was markedly compromised
in the mutant mice (Fig. 4b), suggesting that glucose intolerance is
due to the inadequate supply of insulin from insufficient beta-cell
mass.

only about 42% beta-cell mass of that in controls and displayed
glucose intolerance during IPGTTs (Fig. 3a,b). However, the
female mutant mice still remained glucose tolerant despite an
approximate 39% decrease in beta-cell mass (Fig. 3a,b). In both
male and female mutant mice, the beta cell size and nucleus size
were increased, likely as a compensatory measure (P,0.05,
Fig. 3c,e,f).The total islet number was markedly decreased, mainly
due to the decrease in the number of larger islets, while small islet
number remained similar (P,0.05, Fig. 3d).

Expansion of Beta-cell Mass is Impaired in
RIPCre+Survivinfl/fl Mice after PDL

Absence of Survivin in Beta Cells Leads to Glucose
Intolerance after PDL

To further explore the effects of survivin on beta-cell mass
expansion, we examined pancreatic islet morphology after PDL.
In wild-type control mice, compared to the sham operation group,
beta-cell mass significantly increased by 2.3-fold in the ligated tail
of pancreas at day 7 post PDL (P,0.05, Fig. 5a). The individual
beta cell size and nucleus size remained similar while a 2-fold

To determine whether survivin is necessary for beta-cell
expansion following PDL, we subjected female RIPcre+survivinfl/
fl
and control littermates to PDL or sham operation at 2-month of
age. IPGTTs were performed at day 7 after PDL or sham
operation. Female mice were chosen to eliminate any confounding
PLoS ONE | www.plosone.org
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Figure 3. Survivin deletion in beta cells leads to decreased beta-cell mass. (a) Male and female mutant mice exhibit decreased beta-cell
mass at 2-month of age as compared to controls (n = 5 per genotype). (b) IPGTTs show that the male mutant mice (g) display higher glucose
excursions compared with male controls (m) whereas the female mutant mice (%) show similar responses as female controls (&) (n = 8 per
genotype). (c) Declined beta-cell number is detected in the male and female mutant mice (n = 5 per genotype). (d) Total islet number is decreased in
the mutant mice compared with that in controls in both sexes, mainly due to the decreased definitive islets, with small islets remained similar
(n = 5 per genotype). (e) Increased beta-cell size is observed in the mutant mice in both sexes (n = 5 per genotype). (f) Mutant mice exhibit increased
beta-cell nucleus size in both sexes (n = 5 per genotype). WT, wildtype (black bars); KO, knockout (white bars). The data represent as means 6 SE. *,
p,0.05;**, p,0.01vs control.
doi:10.1371/journal.pone.0041976.g003

increase in beta cell number was observed following the surgery
(P,0.01, Fig. 5b-d). Both the small islet and larger islet number
was markedly increased within the ligated pancreas tail (P,0.05,
Fig. 5e). Small islets likely represented newly formed beta cells
from neogenesis whereas increment in larger islets was likely from

PLoS ONE | www.plosone.org

the replication of preexisting beta cells. So both beta cell
neogenesis and self-duplication of existing beta cells might
contribute to the expansion of beta-cell mass after PDL.
However, beta-cell mass expansion in the RIPCre+Survivinfl/
fl
mice at day 7 post PDL was significantly impaired compared with
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Figure 4. Absence of survivin in beta cells leads to glucose intolerance after PDL. (a) At PDL day 7, female RIPCre+Survivinfl/flmice exhibit
markedly higher glucose excursions during an IPGTT compared with other groups (n = 10 per genotype). (b) In vivo GSIS after i.p. glucose injection is
markedly compromised in the mutant mice compared with that in other groups (n = 10 per genotype). &, RIPCre+Survivin+/+ sham day 7; %,
RIPCre+Survivinfl/fl sham day 7; m, RIPCre+Survivin+/+ PDL day 7; g, RIPCre+Survivinfl/fl PDL day 7. The data represent as means 6 SE. *, p,0.05 vs
sham operation.
doi:10.1371/journal.pone.0041976.g004

day 7 PDL or sham-operated pancreas for genes involved in cell
cycle progression. Compared with sham-operated groups, there
was a marked increase in the expression of Rb1, Ccne1, Cdk2,
Ccna2, Ccnb1 and forkhead box M1 (FoxM1) in wildtype mice
after PDL. However, compared with wildtype controls, there was
an attenuation in the rise of Rb1, Ccne1, Cdk2, and Ccna2 in
response to PDL in the survivin mutant mice. On the other hand,
there was a significant further increase in expression of Ccnb1 and
FoxM1 in survivin mutant mice (Fig. 7b). The attenuation in the
rise of Rb1 gene expression could reflect a compensatory downregulation in an attempt to enhance G1/S transition in cell cycle
[25]. The upregulation of FoxM1 and Ccnb1 gene expression
could also be adaptive changes in an attempt to promote cell cycle
progression [26]. We further explored the expression of mitosisrelated proteins in the islets of ligated pancreas tail. While p21 is
mostly known as a cell cycle inhibitor, it can also promote mitosis
by forming a complex with Caspase-3 and survivin [27]. Aurora B
kinase binds to survivin to form the chromosomal passenger
complex. In the absence of survivin, a decrease in p21, Caspase-3
and Aurora B kinase expression islets were observed after PDL,
which may lead to defective mitosis (Fig. 7c). Our findings support
the hypothesis that survivin is required for beta-cell proliferation in
adults after PDL through cell cycle regulation. Moreover, p-Akt
was significantly decreased in islets of mutant mice (Fig. 7c),
indicating that survivin may also regulate the phosphatidylinositol
3-kinase-Akt signaling pathway which plays an important role in
beta-cell proliferation.
We also examined beta-cell apoptosis in the ligated tail of
pancreas at PDL day 7. The rate of beta-cell apoptosis was low
and not significantly different between the mutant mice and
control wild-type mice after PDL or sham operation (Fig.7d).
Furthermore, we did not detect any significant changes in cleaved
Caspase-3 in the islets of mutant mice compared with controls
(Fig. 7d), indicating that apoptosis did not significantly contribute
to the defect in islet expansion in survivin-deficient beta cells after
PDL.

that of control wild-type mice (P,0.05, Fig. 5a). Similarly, the
increase in beta-cell number was markedly attenuated in the
mutant mice (P,0.05, Fig. 5b). The average beta cell size was
significantly reduced in the ligated pancreas tail of the mutant
mice after PDL compared with sham group, likely due to beta cell
division (P,0.05, Fig. 5c). The beta cell nucleus size remained
increased in the pancreas tail of the mutant mice compared with
that in controls after PDL (P,0.05, Fig. 5d). Although the
increment of total islet number was significantly attenuated in the
mutant mice, it was attributed mainly by the lack of increase in the
number of larger islets while the increment of smaller islets were
similar to that of wild-type mice (P,0.05, Fig. 5e), suggesting that
survivin deletion impairs islet growth after PDL, rather than new
islet formation.
Our previous data have shown that the decreased beta-cell mass
in the mutant mice was not accompanied by abnormal islet
development [20]. However, at day 7 post PDL, survivin-deficient
islets had an abnormal distribution of alpha and beta cells likely
due to impaired beta-cell expansion. The proportion of alpha cells
to beta cells was markedly increased in the mutant mice (P,0.01,
Fig. 6a). However, alpha cell mass was similar in the two groups.
Furthermore, there were no differences in genes expression related
to islet neogenesis such as Ngn3, NeuroD1, Nkx2.2, Nkx6.1, Pdx1
and MafA between the two genotypes (Fig. 6b), suggesting that
survivin deletion in beta cells did not affect islet neogenesis from
endocrine progenitor cells after PDL.

Cell Proliferation is Defective in Survivin-deficient
Betacells after PDL
To elucidate which specific cellular processes are affected in
beta-cell mass expansion in survivin mutant mice after PDL, we
first assessed beta-cell proliferation at PDL day 7. In control
wildtype mice, PDL dramatically increased beta-cell proliferation
by 9-fold in the ligated tail of pancreas compared with the shamoperated group. However, the induction in beta-cell proliferation
in RIPcre+survivinfl/fl mice was significantly blunted, by 4.4-fold
(P,0.05,Fig. 7a). This blunting in the increase of beta cell
proliferation in response to PDL appears to be mainly accounted
by a defect in proliferation of larger islets. In contrast, proliferation
of small islet beta cells was better preserved following PDL
compared to sham operation. These data further suggest that
replication of preexisting beta cells is largely survivin-dependent.
To attempt to gain insight into potential cell cycle proteins
abnormalities, we first performed quantitative PCR on RNA from
PLoS ONE | www.plosone.org

Discussion
Survivin is highly expressed within pancreatic islets during
embryogenesis and neonatal period, however eventually becomes
undetectable by 2-month of age [20,21]. We previously showed
that mice with survivin deleted throughout the pancreatic
epithelium exhibit impaired beta-cell mass establishment and
6

August 2012 | Volume 7 | Issue 8 | e41976

Survivin Regulation of Beta-Cell Mass Expansion

Figure 5. Expansion of beta-cell mass is impaired in RIPCre+Survivinfl/fl mice after PDL. (a) At PDL day 7, beta-cell mass expansion in the
tail of pancreas in RIPcre+survivinfl/fl mice is markedly impaired compared to controls (n = 5 per genotype). (b) The increment of beta-cell number in
the pancreas tail at PDL day 7 is markedly attenuated in the mutant mice compared with that in controls (n = 5 per genotype). (c) Beta-cell size is
decreased in the pancreas tail of the mutant mice at PDL day 7 compared with that in sham-operated pancreas tail, but is still larger than that in PDLtreated controls (n = 5 per genotype). (d) Mutant mice exhibit increased beta-cell nucleus size in the pancreas tail both in PDL and sham-operated
groups (n = 5 per genotype). (e) The increment of total islet number in pancreas tail at PDL day 7 is attenuated in the mutant mice compared to
controls, mainly due to the lack of increase in the number of larger islets (n = 5 per genotype). WT, wildtype; KO, knockout. PDL, black bars; sham
operation, white bars. The data represent as means 6 SE. *p,0.05, **p,0.01 vs sham operation; #P,0.05, ##p,0.01 vs control.
doi:10.1371/journal.pone.0041976.g005

PDL is a normoglycemic pancreatic injury model that stimulates
beta-cell mass expansion by both beta-cell neogenesis from
endogenous progenitors and self-duplication of preexisting beta
cells in adult pancreas [5,22]. We found that PDL led to
resurgence of survivin expression in the islets of the ligated tail
of adult mouse pancreas within 2 weeks during a period of
enhanced beta-cell proliferation. A recent study in mice has shown
that FoxM1 is partially required for proliferation of preexisting

postnatal remodeling secondary to reduced beta-cell proliferation
with perturbations in cell cycle proteins [20]. Here, we show that
survivin expression increases in the islets of the ligated tail of adult
mouse pancreas as early as three days post PDL, which was
correlated with increased beta-cell proliferation and mass expansion. In contrast, RIPcre+survivinfl/fl mice with specific deletion of
survivin in beta cells showed impaired beta-cell mass expansion
following PDL due to defective beta-cell proliferation.

PLoS ONE | www.plosone.org
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Figure 6. Islet development in RIPcre+survivinfl/fl mice and controls after PDL. (a) In day 7 PDL pancreas, insulin and glucagon positive cells
show abnormal distribution in the mutant mice (upper panel, original magnification, 6400). Quantification reveals that the knockout islet has
a markedly higher proportion of alpha cells to beta cells as compared with controls (lowerleft panel). But alpha cell mass is similar in the two groups
(lower right panel) (n = 5 per genotype). (b) Fold change in the expression of the indicated genes related to islet neogenesis as determined by
quatitative PCR are similar in day 7 PDL pancreas in the mutant mice (gray bars) compared with controls (black bars) (n = 5 per genotype). WT,
wildtype; KO, knockout. The data represent as means 6 SE. **p,0.01 vs control.
doi:10.1371/journal.pone.0041976.g006

Because of the lack of survivin expression during embryonic
development and neonatal period, the mutant mice exhibited
a decreased beta-cell mass at 2-month of age compared to wildtype
littermate controls. The male mutant mice displayed glucose
intolerance whereas the female mutant mice remained glucose
tolerant despite the reduced beta-cell mass. This phenomenon has
been observed in other rodent models of diabetes [29–31] and has
been linked to a protective effect of estrogen [32,33]. We took
advantage of this finding and focused on female mice, as this

beta cells stimulated by 60% partial pancreatectomy (PPx) [28].
Survivin, as the known FoxM1 target, was the most significantly
upregulated gene during the peak of beta-cell proliferation
following PPx. Given the multi-regulatory role of survivin in the
various cellular processes, our result demonstrated that survivin
was required for injury-stimulated beta-cell proliferation in adult
mice.
To dissect the physiological role of survivin in beta-cell mass
expansion, we generated RIP-driven survivin knockout mice.
PLoS ONE | www.plosone.org
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Figure 7. Beta-cell proliferation is partially inhibited in RIPCre+Survivinfl/fl mice after PDL. (a) Representative Ki67 and insulin
immunostaining on consecutive pancreatic sections (upper panel) and quantification (lower panel) reveal that PDL markedly stimulates beta-cell
proliferation in the ligated tail of pancreas both in the mutant mice and controls at day 7. However, the increment is significantly attenuated in the
mutant mice as compared to that in controls (left lower panel), especially within larger islets (right lower panel), while the increment is relatively more
preserved in small islets (middle lower panel) (original magnification, 6400; n = 5 per genotype). (b) Fold change in the expression of the indicated
genes related to cell cycle as determined by quatitative PCR in day 7 PDL or sham-operated pancreas in the mutant mice compared with controls
(n = 5 per genotype). (c)Western blots and quantification show a decrease in p21, Caspase-3, Aurora B kinase and phospho-AKT expression in islets of
day 7 PDL pancreas in mutant mice (gray bars) compared to controls (black bars) (n = 5 per genotype). (d) Representative insulin and TUNEL costaining in the ligated tail of pancreas (left panel; original magnification, 6400; apoptotic beta cells are indicated by arrows) and quantification (right
panel) show low rate of beta cell apoptosis at day 7 following ligation or a sham operation with no significant difference between the mutant mice
and controls (n = 5 per genotype). +/+, RIPcre+survivin+/+ mice; 2/2, RIPcre+survivinfl/fl mice. WT, wildtype; KO, knockout. PDL, black bars; sham
operation, white bars. The data represent as means 6 SE. *p,0.05, **p,0.01 vs sham operation; #P,0.05, ##p,0.01 vs control.
doi:10.1371/journal.pone.0041976.g007

would avoid the confounding effects of preexisting defects in
glucose homeostasis. The female mutant mice indeed exhibited
glucose intolerance, compromised beta-cell mass expansion,
blunted increase in islet and beta-cell number, and impaired
beta-cell proliferation following PDL compared to control wildtype littermates after the same procedure.
Importantly, PDL-stimulated beta-cell proliferation was
blunted, but not completely abolished within the ligated tail of
the pancreas in the mutant mice. This may be due to beta-cell
neogenesis. PDL has been shown to activate the progenitors in the
ductal lining to differentiate in Ngn3 dependent way and give rise
to glucose responsive beta cells that subsequently proliferate to
increase the functional beta-cell mass [5]. Gene expressions related
to islet neogenesis such as Ngn3, NeuroD1, Nkx2.2, Nkx6.1, Pdx1
and MafA are similar between the mutant mice and controls,
suggesting that survivin deletion in beta cells does not impair islet
neogenesis after PDL. Although the increment of total islet
number was markedly attenuated in RIPcre+survivinfl/fl mice
compared to wildtype littermates 7 days after PDL, this was largely
due to impairment in the rise in the number of larger islets. In
contrast, rise in the number of smaller islets were relatively
preserved, thereby not significantly contributing to the defect of
islet mass expansion observed in mutant mice. These data support
our observation that small islets represent newly formed beta cells
that likely do not require survivin for its formation or proliferation,
whereas expansion of already-formed islets that arise from
replication of preexisting beta cells appears to require survivin.
The similar phenomenon was found in the FoxM1 knockout mice
after 60% PPx [28]. FoxM1 was not required for proliferation of
beta cells within small endocrine cell clusters located in the
regenerating portion of the pancreas but was specifically required
for proliferation of preexisting beta-cells within largerislets. FoxM1
transactivates genes that coordinate the G1/S and G2/M
transitions, karyokinesis and cytokinesis [26]. As the known
FoxM1 target, survivin fits well within the molecular pathway
downstream of Foxm1 and likely functions to assist them in the
modulating of beta-cell replication. In our study, FoxM1 gene
expression was upregulated by 1.7 fold in survivin mutant mice
after PDL compared with wild-type controls. However, defect in
beta-cell proliferation indicated that the cell cycle promotion effect
of FoxM1 might be mediated through survivin-dependent
pathway.

Survivin plays an important role in cell cycle regulation. During
G1, survivin transcription increases and reaches a peak in G2/M
[34,35]. During mitosis, survivin has been shown to co-localize
with caspase-3 and p21 at the centrosome [36]. As a chromosomal
passenger protein, survivin is involved in chromosome segregation,
central spindle formation, cytokinesis and spindle checkpoint
maintenancethrough its interactions with other passenger proteins,
inner centromere protein and AuroraB kinase [37]. Thus,
disruption of survivin may lead to abnormal centrosome duplication and formation of multipolar spindles, multinucleation and
polyploidy. In keeping with these observations, our in vivo data
reveal that survivin-deficient beta cells have many enlarged nuclei,
together with decreased expression of p21, Caspase-3 and
AuroraB kinase. The decreased gene expression of Rb1 and
Ccne1 could cause the delay on G1/S transition during cell cycle.
In addition, levels of phosphorylated Akt were significantly
decreased in the mutant islets, indicating that the phosphatidylinositol 3-kinase–AKT pathway may be involved in survivin
mediated beta-cell proliferation. Therefore, resurgence of survivin
in response to PDL may be critical in recruiting more beta cells to
enter cell cycle that is necessary for islet expansion.
Taken together, our data show that resurgence of survivin
expression in the pancreatic beta cells after PDL is essential for
beta-cell mass expansion largely through beta-cell proliferation.
The preexisting beta cells seemingly exhibit a stronger requirement for survivin than new beta cells formed by neogenesis. This
study highlights the importance of survivin-dependent replication
of preexisting beta cells as a mechanism of beta-cell mass
expansion. Given that beta cell expansion appears to occur
through proliferation of existing beta cells, survivin may indeed be
a viable therapeutic target for beta cell expansion in diabetes.
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